Evidence map›Paper›PMID 32533240›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Impact of the COVID-19 crisis on imaging in oncological trials.

Christophe M Deroose, Frédéric E Lecouvet, Laurence Collette, Daniela E Oprea-Lager, Wolfgang G Kunz, Luc Bidaut, Joost J C Verhoeff, Caroline Caramella, Egesta Lopci, Bertrand Tombal and 4 more

Abstract readEditorial
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Impact of COVID-19 on Nuclear Medicine in Europe.Seminars in nuclear medicine · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. COVID-19 and the brain: impact on nuclear medicine in neurology.European journal of nuclear medicine and molecular imaging · 2020
    Article
  10. Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology.International journal of radiation oncology, biology, physics · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Christophe M DerooseEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium. christophe.deroose@uzleuven.be.ORCID https://orcid.org/0000-0002-6080-1577
Frédéric E LecouvetEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Laurence ColletteEuropean Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
Daniela E Oprea-LagerEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Wolfgang G KunzEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Luc BidautEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Joost J C VerhoeffEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Caroline CaramellaEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Egesta LopciEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Bertrand TombalCliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Lioe-Fee de Geus-OeiEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Laure FournierEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Marion SmitsEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
Nandita M deSouzaEuropean Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.

Funding

Cancer Research UK 16464
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicCoronavirus InfectionsCOVID-19HumansIncidental FindingsNeoplasmsPandemicsPatient SelectionPneumoniaPneumonia, ViralPolicy

Identifiers

PMID32533240
PMCPMC7289713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.